The Valley Desk

NCT04200963 · Interventional trial

A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma

Overall registry status Completed

Phase 1

Conditions Advanced Cancer, Advanced Solid Tumor, Bladder Cancer, Bladder Disease, Bladder Neoplasm, Bladder Urothelial Carcinoma, Locally Advanced Solid Tumor, Metastatic Bladder Cancer, Metastatic Cancer, Metastatic Urothelial Carcinoma, Neoplasm Malignant, Neoplasm Metastasis, Neoplasm, Bladder, Neoplasm, Urinary Bladder, Neoplasms, Solid Carcinoma, Solid Tumor, Solid Tumor, Adult, Urothelial Carcinoma, Urothelial Carcinoma Bladder, Urothelial Neoplasm

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov